N. Brenwald

2.0k total citations
27 papers, 1.5k citations indexed

About

N. Brenwald is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, N. Brenwald has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 14 papers in Pharmacology and 12 papers in Epidemiology. Recurrent topics in N. Brenwald's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). N. Brenwald is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). N. Brenwald collaborates with scholars based in United Kingdom, Canada and United States. N. Brenwald's co-authors include Richard Wise, Martin J. Gill, Robert A. Wise, J. M. Andrews, F. J. Boswell, J. M. Andrews, R. Wise, J Woodcock, A.P. Fraise and Beryl Oppenheim and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

N. Brenwald

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Brenwald United Kingdom 18 786 709 704 411 238 27 1.5k
Gengrong Lin United States 19 559 0.7× 437 0.6× 537 0.8× 450 1.1× 188 0.8× 36 1.2k
Ronald N. Jones United States 17 550 0.7× 725 1.0× 455 0.6× 262 0.6× 267 1.1× 38 1.4k
M Visalli United States 20 538 0.7× 946 1.3× 613 0.9× 292 0.7× 370 1.6× 32 1.6k
Kim Nichol Canada 19 674 0.9× 756 1.1× 375 0.5× 376 0.9× 178 0.7× 33 1.5k
Jacques Tankovic France 26 653 0.8× 719 1.0× 478 0.7× 522 1.3× 468 2.0× 57 2.1k
Marie-Dominique Kitzis France 19 523 0.7× 799 1.1× 683 1.0× 411 1.0× 305 1.3× 48 1.5k
H Drugeon France 20 534 0.7× 633 0.9× 363 0.5× 694 1.7× 377 1.6× 76 1.7k
Eugenio A. Debbia Italy 21 667 0.8× 541 0.8× 312 0.4× 577 1.4× 271 1.1× 94 1.6k
Aleksandra Wierzbowski Canada 18 578 0.7× 425 0.6× 271 0.4× 282 0.7× 166 0.7× 31 1.1k
Lois M. Ednie United States 24 499 0.6× 456 0.6× 494 0.7× 717 1.7× 243 1.0× 49 1.3k

Countries citing papers authored by N. Brenwald

Since Specialization
Citations

This map shows the geographic impact of N. Brenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Brenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Brenwald more than expected).

Fields of papers citing papers by N. Brenwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Brenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Brenwald. The network helps show where N. Brenwald may publish in the future.

Co-authorship network of co-authors of N. Brenwald

This figure shows the co-authorship network connecting the top 25 collaborators of N. Brenwald. A scholar is included among the top collaborators of N. Brenwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Brenwald. N. Brenwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mark, et al.. (2012). Rapid diagnosis of influenza: An evaluation of two commercially available RT-PCR assays. Journal of Infection. 65(1). 60–63. 12 indexed citations
2.
Brenwald, N., et al.. (2009). Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. Journal of Hospital Infection. 74(3). 245–249. 22 indexed citations
3.
Andrews, J. M., et al.. (2007). Rapid detection of extended-spectrum β-lactamase-producing Gram-negative bacilli in blood cultures. Journal of Antimicrobial Chemotherapy. 60(3). 652–654. 10 indexed citations
4.
Andrews, J. M., G. Jevons, N. Brenwald, & A.P. Fraise. (2004). Susceptibility testing Pasteurella multocida by BSAC standardized methodology. Journal of Antimicrobial Chemotherapy. 54(5). 962–964. 2 indexed citations
5.
Brenwald, N. & A.P. Fraise. (2003). Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA). Journal of Hospital Infection. 55(2). 141–144. 56 indexed citations
6.
Brenwald, N., Peter C. Appelbaum, Todd A. Davies, & M. John Gill. (2003). Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Clinical Microbiology and Infection. 9(2). 140–143. 34 indexed citations
7.
Boswell, F. J., J. M. Andrews, J. P. Ashby, et al.. (1998). The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. Journal of Antimicrobial Chemotherapy. 42(6). 703–709. 61 indexed citations
8.
9.
Andrews, J. M., et al.. (1997). A reassessment of the in-vitro activity of colistin sulphomethate sodium. Journal of Antimicrobial Chemotherapy. 39(2). 255–260. 122 indexed citations
10.
Andrews, J. M., D. Honeybourne, G. Jevons, et al.. (1997). Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy. 40(4). 573–577. 57 indexed citations
11.
Brenwald, N., et al.. (1995). Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques. Journal of Bioluminescence and Chemiluminescence. 10(5). 291–299. 2 indexed citations
12.
Andrews, J., et al.. (1995). The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. Journal of Antimicrobial Chemotherapy. 35(6). 869–876. 76 indexed citations
13.
Fraise, A.P., N. Brenwald, J. M. Andrews, & Robert A. Wise. (1995). In-vitro activity of two glycylcyclines against enterococci resistant to other agents. Journal of Antimicrobial Chemotherapy. 35(6). 877–881. 16 indexed citations
14.
Andrews, J. M., et al.. (1993). The in-vitro activity of a new highly active quinolone, DU-6859a. Journal of Antimicrobial Chemotherapy. 32(5). 757–763. 22 indexed citations
15.
Wise, Robert A., J. M. Andrews, & N. Brenwald. (1993). The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone. Journal of Antimicrobial Chemotherapy. 31(4). 497–504. 41 indexed citations
16.
Wise, Robert A., J. M. Andrews, & N. Brenwald. (1993). The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone. Journal of Antimicrobial Chemotherapy. 31(1). 73–80. 20 indexed citations
17.
Farrington, M., et al.. (1992). Resistance to desiccation and skin fatty acids in outbreak strains of methicillin-resistant Staphylococcus aureus. Journal of Medical Microbiology. 36(1). 56–60. 44 indexed citations
18.
Gray, Jeffrey J. & N. Brenwald. (1991). The use of antibiotics to control bacterial overgrowth of cell cultures used for diagnostic virology. Journal of Virological Methods. 32(2-3). 163–170. 2 indexed citations
19.
Brown, Derek F. J., et al.. (1991). Mechanism of nitrofuran resistance in Salmonella enteritidis Phage type 4 and interpretation of nitrofuran susceptibility tests. Journal of Antimicrobial Chemotherapy. 27(1). 23–28. 7 indexed citations
20.
Brenwald, N., et al.. (1990). Mixed haematogenous endophthalmitis caused by Candida albicans and CDC fermentative corynebacterium group A-4.. British Journal of Ophthalmology. 74(4). 247–248. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gengrong Lin Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by M Visalli Breakdown of academic impact, for papers by Kim Nichol Breakdown of academic impact, for papers by Jacques Tankovic Breakdown of academic impact, for papers by Marie-Dominique Kitzis Breakdown of academic impact, for papers by H Drugeon Breakdown of academic impact, for papers by Eugenio A. Debbia Breakdown of academic impact, for papers by Aleksandra Wierzbowski Breakdown of academic impact, for papers by Lois M. Ednie
Rankless by CCL
2026